Skip to main content

Summit Global Investments

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1697953 BOUNTIFUL, UT

Position in REGN

as of Jun 30, 2026 · filed Aug 3, 2026
Position Value
$4,680,291
-$2,894,671 QoQ
Shares Held
7,506
-23.4% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.60%
of 13F equity value
Holder Rank
#398
of 1,322 holders
Holding Since
Sep 2020
17 quarters on record

Common Shares in REGN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Summit Global Investments holds $20,708,446 across 14 Biotechnology names. REGN ranks #2 (22.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
2 REGN
Regeneron Pharmaceuticals, Inc.
This page
7,506 $4,680,291

All Filings in REGN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $4,680,291 7,506
2026-03-31 $7,574,962 9,804
2025-12-31 $7,581,307 9,822
2025-09-30 $11,033,424 19,623
2025-03-31 $1,758,085 2,772
2024-12-31 $7,204,505 10,114
2024-09-30 $12,476,116 11,868
2024-06-30 $10,166,613 9,673
2024-03-31 $11,861,726 12,324
2023-12-31 $14,262,551 16,239
2023-09-30 $253,471 308
2023-06-30 $215,562 300
2021-09-30 $11,398,565 18,835
2021-06-30 $9,104,202 16,300
2021-03-31 $7,374,833 15,587
2020-12-31 $390,352 808
2020-09-30 $336,427 601